Klinik und Poliklinik für Geburtshilfe und Frauengesundheit
Klinikum / Johannes Gutenberg-Universität Mainz
Geberth, M; Foerster, F; Klare, P et al.
Efficacy and Safety of First-Line Bevacizumab (BEV) Combined with Paclitaxel (PAC) According to Age: Subpopulation Analysis of a Large, Multicenter, Non-Interventional Study in Patients (Pts) with HER2-Negative Metastatic Breast Cancer (MBC).CANCER RESEARCH. Bd. 69. H. 24. 2009 S. 851S-852S
Keller, K; Böhm, D; Lebrecht, A et al.
Eine vielversprechende Methode zur Visualisierung der Antikörper-Profile in ImmunproteomicsSenologie - Zeitschrift für Mammadiagnostik und -therapie. Bd. 6. 2009 S. A61
Kalkum, G; Macchiella, D; Reinke, J et al.
Enzyme replacement therapy with agalsidase alfa in pregnant women with Fabry disease.Eur J Obstet Gynecol Reprod Biol. Bd. 144. H. 1. 2009 S. 92-3
Foerster, F; Geberth, M; Schumacher, C et al.
First-line bevacizumab (bev) plus paclitaxel (pac) combination therapy: safety findings (n=165) from a multicentre German non-interventional study in patients with metastatic breast cancer (MBC)EJC SUPPLEMENTS. Bd. 7. H. 2. 2009 S. 283-283
Petry, IB; Fieber, F; Gebhard, S et al.
HER-2/neu induces an anti-apoptotic expression patterns of Bcl-2 family members in node-negative Breast cancerGeburtshilfe und Frauenheilkunde. Bd. 69. H. 8. 2009 S. 754
Schmidt, M; Hesse, T; Kuehnle, H et al.
Ibandronate Shows Marked Pain Relief and a Favorable Renal Safety Profile - Updated Results of a Non Interventional Study in Breast Cancer Patients with Metastatic Bone DiseaseCANCER RESEARCH. Bd. 69. H. 24. 2009 S. 573S-573S
Schmidt, M; Boehm, D; Lebrecht, A et al.
Immunoglobulin Kappa C Has Independent Prognostic Significance in Node-Negative Breast CancerCANCER RESEARCH. Bd. 69. H. 24. 2009 S. 729S-729S
Schmidt, M; Petry, IB; Bohm, D et al.
Influence of Immunoglobulin Kappa C on the metastasis-free survival in adjuvant untreated node-negative Breast cancer.GEBURTSHILFE UND FRAUENHEILKUNDE. Bd. 69. H. 8. 2009 S. 759-759
Skala, CE; Petry, IB; Gebhard, S et al.
Isolation of fibroblasts for coating of meshes for reconstructive surgery: differences between mesh types.Regen Med. Bd. 4. H. 2. 2009 S. 197-204
Naumann, G
Ist eine chirurgische Therapie der Mischinkontinenz sinnvoll?F. Perabo, S.C. Müller (Hrsg). Inkontinenz. 1. Aufl. Köln: Deutscher Ärzteverlag 2009